1 completed, 1 not yet recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
Follow AIS: new trials by email Literature Review of AIS trials Research Report on AIS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke Placebo of Human Umbilical Cord Mesenchymal Stromal Cells Injection, Human Umbilical Cord Mesenchymal Stem Cells Injection - Acute Ischemic Stroke, AIS | Phase 1 | Not yet recruiting | BOE Technology Group Co., Ltd. | 35 | 2026-06-30 | 2026-06-05 |
| Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females 9-valent HPV Recombinant Vaccine, Placebo - Cervical Cancers, Vulvar Cancer | Phase 1 | Completed | Shanghai Bovax Biotechnology Co., Ltd. | 90 | 2018-10-10 | 2020-01-22 |
Condylomata Acuminata (1) · Ischemic Stroke (1) · Uterine Cervical Neoplasms (1) · Vaginal Neoplasms (1) · Vulvar Neoplasms (1)
Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Infections (1) · Neoplasms (1) · Neoplasms by Site (1)
BOE Technology Group Co., Ltd. (1) · Shanghai Bovax Biotechnology Co., Ltd. (1)
China (2)